Skip to content

Analgesic effect of bupivacaine liposome paraspinal nerve block on postoperative patients undergoing thoracoscopic lobectomy

Analgesic effect of bupivacaine liposome paraspinal nerve block on postoperative patients undergoing thoracoscopic lobectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099400
Enrollment
Unknown
Registered
2025-03-24
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Interventions

PVB group:Bupivacaine liposome paravertebral nerve block
PCIA group:Patient-controlled intravenous analgesia

Sponsors

Hebei Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Sixty patients with elective thoracoscopic lobectomy under general anesthesia, regardless of gender, aged 18-64 years, ASA grade I or II, BMI 18~26 kg/m 2, The postoperative plan is to transfer to the ward.

Exclusion criteria

Exclusion criteria: 1. Allergy to general anesthetics and study drugs; 2. Coagulation dysfunction; 3. Combined with mental disorders, unable to cooperate; 4. Alcoholism or heavy dependence on narcotic drugs.

Design outcomes

Primary

MeasureTime frame
First pain relief time;Incidence of postoperative pain relief;

Secondary

MeasureTime frame
Interleukin-6;C-reaction protein;Cyclophenol;Remifentanil;Time of first ground activity after surgery;Postoperative nausea and vomiting;Infection at the puncture site;

Countries

China

Contacts

Public ContactLi Xiangnan

Hebei Provincial People's Hospital

810441720@qq.com+86 150 7513 7522

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026